Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
BMJ Open Respiratory Research
|
March 11, 2026
Sex differences in efficacy and adverse events following bronchoscopic thermal vapour ablation for severe emphysema: results from a multinational real-world registry
Franziska C Trudzinski, Konstantina Kontogianni, Arschang Valipour, et al.
Translational Lung Cancer Research
|
March 15, 2021
KRAS<sup>G12C</sup>/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma
Nikolaj Frost, Jens Kollmeier, Claudia Vollbrecht, et al.
ERJ Open Research
|
August 23, 2023
Assessment of efficacy and safety of endoscopic lung volume reduction with one-way valves in patients with a very low FEV<sub>1</sub>
Thomas Sgarbossa, Pavlina Lenga, Franz Stanzel, et al.
COPD
|
March 10, 2025
Efficacy and Safety of Lung Volume Reduction with Endobronchial Coil #2 and Coil #4 Results of the German Emphysema Registry-Lungenemphysemregister e.V
Christian Grah, Shiao Li Oei, Joanna Krist, et al.
The European Respiratory Journal
|
March 21, 2015
Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer
Michael Thomas, Jürgen Fischer, Stefan Andreas, et al.
The Lancet. Respiratory Medicine
|
February 23, 2016
Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial
Felix J F Herth, Arschang Valipour, Pallav L Shah, et al.
ERJ Open Research
|
January 15, 2025
Clinical improvements after endoscopic lung volume reduction with valves in patients with advanced emphysema and a 6-min walk test ≤140 m at baseline
Jacopo Saccomanno, Lara Kilic, Thomas Sgarbossa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 3, 2026
Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315)
Friederike C Althoff, Horst-Dieter Hummel, Konrad Kokowski, et al.
The Lancet. Respiratory Medicine
|
July 25, 2016
Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results
Pallav L Shah, Daniela Gompelmann, Arschang Valipour, et al.
Respiration; International Review of Thoracic Diseases
|
July 5, 2022
Endoscopic Lung Volume Reduction with One-Way Valves in Patients with Severe Chronic Obstructive Pulmonary Disease with Hypercapnia
Pavlina Lenga, Christian Grah, Christoph Ruwwe-Glösenkamp, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
BMJ Open Respiratory Research
|
March 11, 2026
Sex differences in efficacy and adverse events following bronchoscopic thermal vapour ablation for severe emphysema: results from a multinational real-world registry
Franziska C Trudzinski, Konstantina Kontogianni, Arschang Valipour, et al.
Translational Lung Cancer Research
|
March 15, 2021
KRAS<sup>G12C</sup>/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma
Nikolaj Frost, Jens Kollmeier, Claudia Vollbrecht, et al.
ERJ Open Research
|
August 23, 2023
Assessment of efficacy and safety of endoscopic lung volume reduction with one-way valves in patients with a very low FEV<sub>1</sub>
Thomas Sgarbossa, Pavlina Lenga, Franz Stanzel, et al.
COPD
|
March 10, 2025
Efficacy and Safety of Lung Volume Reduction with Endobronchial Coil #2 and Coil #4 Results of the German Emphysema Registry-Lungenemphysemregister e.V
Christian Grah, Shiao Li Oei, Joanna Krist, et al.
The European Respiratory Journal
|
March 21, 2015
Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer
Michael Thomas, Jürgen Fischer, Stefan Andreas, et al.
The Lancet. Respiratory Medicine
|
February 23, 2016
Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial
Felix J F Herth, Arschang Valipour, Pallav L Shah, et al.
ERJ Open Research
|
January 15, 2025
Clinical improvements after endoscopic lung volume reduction with valves in patients with advanced emphysema and a 6-min walk test ≤140 m at baseline
Jacopo Saccomanno, Lara Kilic, Thomas Sgarbossa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 3, 2026
Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315)
Friederike C Althoff, Horst-Dieter Hummel, Konrad Kokowski, et al.
The Lancet. Respiratory Medicine
|
July 25, 2016
Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results
Pallav L Shah, Daniela Gompelmann, Arschang Valipour, et al.
Respiration; International Review of Thoracic Diseases
|
July 5, 2022
Endoscopic Lung Volume Reduction with One-Way Valves in Patients with Severe Chronic Obstructive Pulmonary Disease with Hypercapnia
Pavlina Lenga, Christian Grah, Christoph Ruwwe-Glösenkamp, et al.
Page
of 5